Role of Fas/Fas ligand-mediated apoptosis in murine contact hypersensitivity

International Immunopharmacology

Volumn 3, Issue 7, 2003, Pages 927-938

  Xu, Baohui ^a   Bulfone Paus, Sivia ^b   Aoyama, Kohji ^a   Yu, Su ^c   Huang, Peixin ^d   Morimoto, Kanehisa ^d   Matsushita, Toshio ^a,e   Takeuchi, Toru ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e I'M Building   (Japan)

Author keywords

Apoptosis; Contact hypersensitivity; Cytokine; Fas; Mice

Indexed keywords

ALLERGEN; CD4 ANTIGEN; DNA; FAS ANTIGEN; FAS LIGAND; FLUORESCEIN ISOTHIOCYANATE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 4; LIPOCORTIN 5; MESSENGER RNA; MUTANT PROTEIN; OXAZOLONE; PROPIDIUM IODIDE; PROTEIN BAX;

ABDOMEN; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTACT ALLERGY; CONTACT SENSITIZATION; CONTROLLED STUDY; DNA DETERMINATION; EAR; FEMALE; FLOW CYTOMETRY; IMMUNOPATHOGENESIS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROVOCATION TEST; SIGNAL TRANSDUCTION; SKIN INFLAMMATION; SKIN SENSITIZATION; STATISTICAL SIGNIFICANCE; STRAIN DIFFERENCE; T LYMPHOCYTE; TH2 CELL; WILD TYPE;

EID: 0038519487     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(03)00081-X     Document Type: Article

References (44)

1. + T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J. Immunol. 144:1990;4121-4128.
2. + type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J. Immunol. 165:2000;6783-6790.
3. + T cell-mediated contact hypersensitivity. J. Exp. Med. 189:1999;779-786.
4. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787-793.
5. Mohler K.M., Butler L.D. Differential production of IL-2 and IL-4 mRNA in vivo after primary sensitization. J. Immunol. 145:1990;1734-1739.
6. Gautam S.C., Chikkala N.F., Hamilton T.A. Anti-inflammatory action of IL-4. Negative regulation of contact sensitivity to trinitrochlorobenzene. J. Immunol. 148:1992;1411-1415.
7. Asherson G.L., Dielli F., Sireci G., Salerno A. Role of IL-4 in delayed type hypersensitivity. Clin. Exp. Immunol. 103:1996;1-4.
8. Ohmen J.D., Hanitifin J.M., Nickoloff B.J., Rea T.H., Wyzykowski R., Kim J.et al. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J. Immunol. 154:1995;1956-1963.
9. Riemann H., Schwarz A., Grabbe S., Aragane Y., Luger T.A., Wysocka M.et al. Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance. J. Immunol. 156:1996;1799-1803.
10. Muller G., Saloga J., Germann T., Schuler G., Knop J., Enk A.H. IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. J. Immunol. 155:1995;4661-4668.
11. Xu B.H., Aoyama K., Kitani A., Yu S., Matsuyama T., Matsushita T. Interleukin-12 enhances contact hypersensitivity by modulating the in vivo cytokine pattern in mice. J. Interferon Cytokine Res. 18:1998;23-31.
12. Yokozeki H., Ghoreishi M., Takagawa S., Takayama K., Satoh T., Katayama I.et al. Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity. J. Exp. Med. 191:2000;995-1004.
13. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
14. Krammer P.H. CD95's deadly mission in the immune system. Nature. 407:2000;789-795.
15. Zhang X., Brunner T., Carter L., Dutton R.W., Rogers P., Bradley L.et al. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J. Exp. Med. 185:1997;1837-1849.
16. Varadhachary A.S., Perdow S.N., Hu C., Ramanarayanan M., Salgame P. Differential ability of T cell subsets to undergo activation-induced cell death. Proc. Natl. Acad. Sci. U. S. A. 94:1997;5778-5783.
17. Vandenbark A.A., Barnes D., Finn T., Bourdette D.N., Whitham R., Robey I.et al. Differential susceptibility of human T(h)1 versus T(h)2 cells to induction of energy and apoptosis by ECDI/antigen-coupled antigen-presenting cells. Int. Immunol. 12:2000;57-66.
18. Ramsdell F., Seaman M.S., Miller R.E., Picha K.S., Kennedy M.K., Lynch D.H. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int. Immunol. 6:1994;1545-1553.
19. Oberg H.H., Lengl-Janssen B., Kabelitz D., Janssen O. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype. Cell. Immunol. 181:1997;93-100.
20. Xu B.H., Aoyama K., Kitani A., Matsuyama T., Matsushita T. Expression of cytokine mRNAs in the draining lymph nodes following contact in mice. Toxicol. Methods. 7:1997;137-148.
21. Xu B.H., Aoyama K., Yu S., Kitani A., Okamura H., Kurimoto M.et al. Expression of interleukin-18 in murine contact hypersensitivity. J. Interferon Cytokine Res. 18:1998;653-659.
22. Xu B.H., Aoyama K., Kitani A., Matsuyama T., Matsushita T. RT-PCR analysis of in vivo cytokine profiles in murine allergic contact dermatitis to DNCB. Toxicol. Methods. 6:1996;23-31.
23. Hauser C. Cultural epidermal Langerhans cells activate effector T cells for contact hypersensitivity. J. Invest. Dermatol. 95:1990;436-440.
24. Rivas J.M., Ullrich S.E. Systemic suppression of delayed type hypersensitivity by supernatants from UV-irradiated keratinocytes: an essential role for keratinocyte-derived IL-10. J. Immunol. 149:1992;3865-3871.
25. Ferguson T.A., Dube P., Griffith T.A. Regulation of contact hypersensitivity by interleukin 10. J. Exp. Med. 179:1994;1579-1604.
26. Berg D.J., Leach M.W., Kuhn R., Rajewsky K., Muller W., Davidson N.J.et al. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J. Exp. Med. 182:1995;99-108.
27. Gao Y.K., Herndon J.M., Zhang W., Griffith T.S., Feruson T.A. Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J. Exp. Med. 188:1998;887-896.
28. Orteu C.H., Poulter L.W., Rustin M.H., Sabin C.A., Salmon M., Akbar A.N. The role of apoptosis in the resolution of T cell-mediated cutaneous inflammation. J. Immunol. 161:1998;1619-1629.
29. Trautmann A., Akidis M., Kleemann D., Altznauer F., Simon H., Graeve T.et al. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J. Clin. Invest. 106:2001;25-35.
30. Carlsten H., Tarkowski A., Nilsson L.A. The effect of immunomodulating treatment on cutaneous delayed type hypersensitivity in MRL lpr/lpr mice. APMIS. 97:1989;728-732.
31. Schwarz A., Grabbe S., Grosse-Heitmeyer K., Roters B., Riemann H., Luger T.A.et al. Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system. J. Immunol. 160:1998;4262-4270.
32. Hill L.L., Shreedhar V.K., Kripke M.L., Owen-Schaub L.B. A critical role for Fas ligand in the active suppression of systemic immune responses by ultraviolet radiation. J. Exp. Med. 189:1999;1285-1293.
33. Sabelko K.A., Kelly K.A., Nahm M.H., Cross A.H., Russell J.H. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J. Immunol. 159:1997;3096-3099.
34. Waldner H., Sobel R.A., Howard E., Kuchroo V.K. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J. Immunol. 159:1997;3100-3103.
35. Kuwano K., Hagimoto N., Kawasaki M., Yatomi T., Nakamura N., Nagata S.et al. Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J. Clin. Invest. 104:1999;13-19.
36. Zubiaga A.M., Munoz E., Huber B.T. IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid-induced apoptosis. J. Immunol. 149:1992;107-112.
37. Huang F.P., Xu D., Esfandiari E.O., Sands W., Wei X.Q., Liew F.Y. Mice defective in Fas are highly susceptible to Leishmania major infection despite elevated IL-12 synthesis, strong Th1 responses, and enhanced nitric oxide production. J. Immunol. 160:1998;4143-4147.
38. Enk A.H., Katz S.I. Identification and induction of keratinocyte-derived IL-10. J. Immunol. 149:1992;92-95.
39. Matute-Bello G., Winn R.K., Jonas M., Chi E.Y., Martin T.R., Liles W.C. Fas (CD95) induces alveolar epithelial cell apoptosis in vivo. Implications for acute pulmonary inflammation. Am. J. Pathol. 158:2001;153-161.
40. Schaub F.J., Han D.K.M., Liles W.C., Adams L.D., Coats S.A., Ramachandran R.K.et al. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat. Med. 6:2000;790-796.
41. Antonopoulos C., Cumberbatch M., Dearman R.J., Daniel R.J., Kimber I., Groves R.W. Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J. Immunol. 166:2001;3672-3677.
42. Henkart P. ICE family proteases: mediators of all apoptotic cell death? Immunity. 4:1996;195-201.
43. Aiba-Masago S., Masago R., Vela-Roch N., Talal N., Dang H. Fas-mediated apoptosis in a rat acinar cell line is dependent on caspase-1 activity. Cell. Signal. 9:2001;17-24.
44. Takahashi H., Nakamura S., Asano K., Kinouchi M., Ishida-Yamamoto A., Iizuka H. Fas antigen modulates ultraviolet B-induced apoptosis of SVHK cells: sequential activation of caspase 8, 3, and 1 in the apoptotic process. Exp. Cell Res. 249:1999;291-298.